Jakob L. Fischer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Articles (1)
Key Points Military servicemembers reported high satisfaction rates of dupilumab treatment for CRSwNP. Some service members fear that dupilumab treatment may limit their career progression. Updated guidelines are needed for servicemembers to make decisions regarding dupilumab.
Year:
2023
Collaborators (1)
Anthony Tolisano
Uniformed Services University of the Health Sciences
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.